French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1
Pierre Goudet(Inserm), Antoine Tabarin(Université de Bordeaux), Thomas Walter(University Hospital Waterford), Muriel Mathonnet(Inserm), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), Louis de Mestier(Inserm), Catherine Cardot-Bauters(Centre Hospitalier Universitaire de Lille), Anne Barlier(Inserm), Guillaume Cadiot(Centre Hospitalier Universitaire de Reims), Philippe Chanson(Bicêtre Hospital), Robert Caïazzo(Université de Lille), Éric Mirallié(Centre Hospitalier Universitaire de Nantes), Lionel Groussin(Université Paris Cité), Christophe Trésallet(Sorbonne Université), Françoise Borson‐Chazot(Hospices Civils de Lyon), Laurent Brunaud, Éric Baudin(Institut Gustave Roussy), Sébastien Gaujoux(Délégation Paris 5), Thomas Cuny(Hôpital de la Conception), F. Sébag(Hôpital de la Conception), M. Le Bras(Centre Hospitalier Universitaire de Nantes), Sophie Giraud(Hospices Civils de Lyon), Éric Dansin(Centre Oscar Lambret), Pauline Romanet(Inserm), Frédéric Castinetti(Inserm), Jean‐Christophe Lifante(Lyon 1 Université), François Pattou(Inserm)
Cited by 28
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
|Neuroendocrinology|2012|869
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791